Levetiracetam

NDC 27808-265 · Cranbury Pharmaceuticals, LLC

Generic nameLevetiracetam

Dosage formTABLET

RouteORAL

Active ingredient(s)LEVETIRACETAM

Strength750 mg/1

Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

27808-265-01 — 120 TABLET in 1 BOTTLE (27808-265-01)

27808-265-02 — 500 TABLET in 1 BOTTLE (27808-265-02)

FDA lists these products with the same active ingredient.

16714-035 — Levetiracetam, 16714-310 — Levetiracetam, 16714-358 — Levetiracetam, 16714-537 — Levetiracetam, 17856-0574 — Levetiracetam, 25021-793 — levetiracetam, 25021-794 — levetiracetam, 25021-795 — levetiracetam, 27808-263 — Levetiracetam, 27808-264 — Levetiracetam, 27808-266 — Levetiracetam, 31722-536 — Levetiracetam, 31722-537 — Levetiracetam, 31722-538 — Levetiracetam, 31722-539 — Levetiracetam, 31722-574 — Levetiracetam oral, 36000-352 — levetiracetam, 36000-354 — levetiracetam, 36000-356 — levetiracetam, 39328-511 — Levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.